Discover the latest articles and insights about Pharmaceuticals
Trump administration rolls out steep tariffs on patented drugs The White House announced on Thursday that all patented medicines entering the United States will face a 100 % import duty, though p...
Weight-loss medications transform lives but aren't a standalone cure New appetite-suppressing drugs like semaglutide and tirzepatide have delivered dramatic results for individuals battling obesi...
Financial sacrifices pay off for self-funded patient Ruth Gonzalez, 56, began taking Eli Lilly's Zepbound last year after her blood pressure spiked, but the $350 monthly cost forced her to cut ba...
Patent expiry sets stage for generic competition India's pharmaceutical market is bracing for a seismic shift as the patent on semaglutide-the active ingredient in Novo Nordisk's blockbuster weig...
Updated February 13, 2026 - Investigation reveals widespread harm from dopamine agonist drugs, prompting calls for stronger warnings. Twelve years of ruin: A solicitor's fall Frances arrived a...
Novo Nordisk files lawsuit to block rival's weight-loss products Novo Nordisk, the Danish manufacturer of Ozempic and Wegovy, has taken legal action against Hims & Hers, accusing the company...
Novo Nordisk stock plummets after profit warning Shares of the Danish pharmaceutical giant Novo Nordisk fell sharply Wednesday after executives predicted a steep decline in profits and sales, cit...
Surge in weight-loss drug use alters consumer behavior Approximately 1.6 million people in the UK used weight-loss injections in 2024, with millions more expressing interest, according to Univers...
FDA greenlights Wegovy pill, a first in weight-loss treatment The US Food and Drug Administration has approved a pill version of the weight-loss medication Wegovy, developed by Danish pharmaceuti...
Weight-loss drugs silence hunger-but at what cost? For millions using GLP-1 medications like Wegovy and Mounjaro, the drugs have muted the persistent mental chatter urging them to eat. Yet stoppi...
UK and US Reach Tariff Agreement on Pharmaceutical Trade The UK and US governments have finalized a trade agreement ensuring zero tariffs on British pharmaceutical exports to the US for the next...
Off-label use of weight-loss drugs grows among non-obese users A rising number of individuals with no medical need for weight-loss injections are using them intermittently for cosmetic purposes,...
Trump administration negotiates lower prices for obesity medications The Trump administration announced agreements with Eli Lilly and Novo Nordisk on Friday to reduce monthly costs of popular wei...
Kimberly-Clark announces $40bn acquisition of Kenvue amid market pressures Kimberly-Clark, the manufacturer of household staples like Kleenex and Huggies, has agreed to acquire Kenvue-the maker o...
India's weight-loss drug boom sparks medical and ethical concerns Mumbai diabetologist Rahul Baxi now fields daily inquiries from young professionals seeking prescriptions for weight-loss drugs-o...
Response Time: We aim to respond to all inquiries within 30 days.
Email: support@news.com
Help us improve by reporting any issues with this response.
Thank you for your feedback
